GABP Promotes Mesangial Cell Proliferation and Renal Fibrosis Through GLI1 in Diabetic Nephropathy
Advanced Science · 2025
DOI: 10.1002/advs.202407462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Lei Du und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Cell Proliferation, Zinc Finger Protein GLI1, Mesangial Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Innovation Plan for Postgraduates of Jiangsu Province.
Abstract (Originalsprache)
Abnormal proliferation of mesangial cells is a hallmark of diabetic nephropathy (DN). However, the cellular signaling mechanisms that regulate this proliferation remain poorly understood. In this study, it is demonstrated that GA‐binding protein (GABP), a member of the ETS family of transcription factors composed of GABPα and GABPβ, plays a significant role in the development of renal fibrosis by modulating mesangial cell proliferation. Notably, the deficiency of GABP in mesangial cells inhibits hyperglycemia‐induced proliferation and mitigates renal fibrosis in a murine model of type 2 diabetes mellitus (T2DM). RNA sequencing analysis identifies GLI Family Zinc Finger 1 (GLI1) as the principal downstream effector of GABP in diabetic mice, serving as a crucial regulator of the G1/S transition within the cell cycle. Subsequent investigations have demonstrated that GABP interacts with the GLI1 promoter, facilitating mesangial cell proliferation via GLI1‐dependent pathways. This is evidenced by the fact that GLI1 knockdown abrogates the proliferation of mesangial cells with GABP overexpression. Consequently, GABP emerges as a pivotal regulator of renal fibrosis and represents a promising therapeutic target for the treatment of diabetic nephropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, China.
ORCID-Profile: Lei Du
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
- Innovation Plan for Postgraduates of Jiangsu Province
Zitieren
APA
Du, L., Liu, S., Lu, Y., Ren, D., Yu, X., Hu, Y., Yang, T., Yang, Q., Ming, J., Zhang, J., Yin, X., & Lu, Q. (2025). GABP Promotes Mesangial Cell Proliferation and Renal Fibrosis Through GLI1 in Diabetic Nephropathy. Advanced Science. https://doi.org/10.1002/advs.202407462
Vancouver
Du L, Liu S, Lu Y, Ren D, Yu X, Hu Y, et al. GABP Promotes Mesangial Cell Proliferation and Renal Fibrosis Through GLI1 in Diabetic Nephropathy. Advanced Science. 2025. doi:10.1002/advs.202407462
BibTeX
@article{Du2025,
author = {Du, Lei and Liu, Sijie and Lu, Yinfei and Ren, Dongxue and Yu, Xiujuan and Hu, Yue and Yang, Tingting and Yang, Qun and Ming, Jingxian and Zhang, Jiawei and Yin, Xiaoxing and Lu, Qian},
title = {GABP Promotes Mesangial Cell Proliferation and Renal Fibrosis Through GLI1 in Diabetic Nephropathy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202407462}
}
EUVIMED